Genentech
TECENTRIQ
Manufacturer:
Genentech
Name:
TECENTRIQ
HCPCS Code Descriptor:
Injection, atezolizumab, 10 mg
Category:
J Code
HCPCS:
J9022
NDC(s):
50242-0917-01, 50242-0918-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
TECENTRIQ is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9022 is aligned to the drug TECENTRIQ.